GTN vs Isosorbide Dinitrate for Angina Management
Key Pharmacological Differences
- GTN acts within 1-7 minutes, making it ideal for acute angina relief, while isosorbide dinitrate has a slower onset but longer duration, making it better suited for angina prophylaxis 1
- The European Society of Cardiology recommends rapidly acting nitroglycerin formulations, such as GTN sublingual or spray, for acute angina attacks 2, 3
Clinical Indications
- For acute angina relief, use GTN sublingual (0.3-0.6 mg) or spray (0.4 mg) as first-line for immediate symptom relief 1
- Patients should sit during first use of GTN to prevent postural hypotension 4
- ISDN (5-80 mg, 2-3 times daily) is indicated for prevention of angina, but not for acute episodes 1
Dosing Strategies and Tolerance Prevention
- Both GTN and ISDN require a daily "nitrate-free interval" of 10-12 hours to prevent tolerance 1, 2, 3
- Tolerance develops after 24 hours of continuous therapy and is dose and duration dependent 1
Side Effects and Precautions
- Common side effects of both GTN and ISDN include dose-dependent headache 1, 2, postural hypotension, especially with overdosing 1, 2, 3, and reflexogenic tachycardia leading to "paradoxical" angina with excessive dosing 2, 3
- An angina attack not responding to short-acting nitroglycerin should be regarded as possible myocardial infarction 2, 3
Practical Algorithm for Use
- For acute angina attacks, use GTN sublingual/spray for immediate relief 1, 4
- For situational prophylaxis, use prophylactic GTN before activity 5
- For chronic angina prevention, use ISDN 2-3 times daily with nitrate-free intervals 1
Integration with Overall Angina Management
- Nitrates are symptomatic therapy only and do not improve prognosis 3
- First-line prognostic therapy includes aspirin 75 mg daily, statin therapy, and beta-blockers 4
- Beta-blockers should be optimized first, with nitrates added for additional symptom control 6
- Short-acting nitrate consumption serves as a useful measure of treatment effectiveness with other anti-anginal drugs 2, 3